PMAIP1 and Cognitive impairment: Associated with AD in the mouse T2D PC2, we identified MED13L48 and XBP149 connected to cognitive deficits, changes in mitochondrial metabolism (PMAIP1)50, inflammation (RASGRP1)51, and the expression of NRIP152 reduced in AD.